Mechanisms of recurrence of Ta/T1 bladder cancer

被引:69
|
作者
Bryan, Richard T. [1 ,2 ]
Collins, Stuart I. [3 ]
Daykin, Mark C. [4 ]
Zeegers, Maurice P. [5 ,6 ]
Cheng, K. K. [2 ]
Wallace, D. Michael A. [7 ]
Sole, Graham M. [4 ]
机构
[1] Univ Birmingham, Bladder Canc Prognosis Programme, Dept Publ Hlth Epidemiol & Biostat, Sch Populat Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England
[3] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham B15 2TT, W Midlands, England
[4] Cty Hosp, Dept Urol, Hereford HR1 2ER, England
[5] Univ Birmingham, Unit Genet Epidemiol, Dept Publ Hlth Epidemiol & Biostat, Sch Populat Sci, Birmingham B15 2TT, W Midlands, England
[6] Maastricht Univ, Dept Complex Genet Cluster Genet & Cell Biol, Nutr & Toxicol Res Inst Maastricht, Maastricht, Netherlands
[7] Queen Elizabeth Hosp, Dept Urol, Birmingham B15 2TH, W Midlands, England
关键词
Bladder cancer; Mechanisms; Recurrence; TRANSURETHRAL RESECTION; INTRAVESICAL CHEMOTHERAPY; URINARY-TRACT; MITOMYCIN-C; FOLLOW-UP; CARCINOMA; OLIGOCLONALITY; PROGRESSION; DIAGNOSIS; BIOPSIES;
D O I
10.1308/003588410X12664192076935
中图分类号
R61 [外科手术学];
学科分类号
摘要
INTRODUCTION Bladder cancer recurrence occurs via four mechanisms - incomplete resection, tumour cell re-implantation, growth of microscopic tumours, and new tumour formation. The first two mechanisms are influenced by clinicians before and immediately after resection; the remaining mechanisms have the potential to be influenced by chemopreventive agents. However, the relative importance and timing of these mechanisms is currently unknown. Our objective was to postulate the incidence and timing of these mechanisms by investigating the location of bladder cancer recurrences over time. PATIENTS AND METHODS The topographical locations of tumours and their recurrences were analysed retrospectively for 169 patients newly-diagnosed with Ta/T1 bladder cancer, with median follow-up of 33.8 months. Tumours were assigned to one or more of six bladder sectors, and time to recurrence and location of recurrences were recorded. RESULTS Median time to first tumour recurrence was 40 months. Median times between subsequent recurrences were 6.6, 7.9, 8.0 and 6.6 months for recurrences 1 to 2, 2 to 3, 3 to 4, and 4 to 5, respectively. The risk of first tumour recurrence in any given bladder sector increased by nearly 4-fold if the primary tumour was resected from that sector (P < 0.001); this association was not significant for subsequent recurrences. The proportion of tumour recurrences in multiple bladder sectors increased from 13% for the first recurrence to 100% for recurrence seven onwards. CONCLUSIONS First tumour recurrence appears different to subsequent recurrences; incomplete resection and tumour cell re-implantation may dominate at this time-point. Only later does genuine new tumour formation appear to increase in importance. This has important implications for clinical trials, especially those involving chemopreventive agents.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 50 条
  • [1] Mechanisms of Recurrence of Ta/T1 Bladder Cancer Editorial Comment
    Wood, David P.
    [J]. JOURNAL OF UROLOGY, 2011, 185 (05): : 1642 - 1642
  • [2] TA AND T1 BLADDER-CANCER - LOCATION, RECURRENCE AND PROGRESSION
    HENEY, NM
    NOCKS, BN
    DALY, JJ
    PROUT, GR
    NEWALL, JB
    GRIFFIN, PP
    PERRONE, TL
    SZYFELBEIN, WA
    [J]. BRITISH JOURNAL OF UROLOGY, 1982, 54 (02): : 152 - 157
  • [3] REG1A predicts recurrence in stage Ta/T1 bladder cancer
    Geng, J.
    Fan, J.
    Wang, P.
    Fang, Z. J.
    Xia, G. W.
    Jiang, H. W.
    Chen, G.
    Ding, Q.
    [J]. EJSO, 2009, 35 (08): : 852 - 857
  • [4] Tumour location adjacent to the ureteric orifice in primary Ta/T1 bladder cancer is predictive of recurrence
    Jancke, Georg
    Rosell, Johan
    Jahnson, Staffan
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2016, 50 (01) : 33 - 38
  • [5] Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer
    Xu, Tianyuan
    Zhu, Zhaowei
    Wang, Xianjin
    Xia, Leilei
    Zhang, Xiaohua
    Zhong, Shan
    Sun, Fukang
    Zhu, Yu
    Shen, Zhoujun
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (07) : 1135 - 1141
  • [6] Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer
    Tianyuan Xu
    Zhaowei Zhu
    Xianjin Wang
    Leilei Xia
    Xiaohua Zhang
    Shan Zhong
    Fukang Sun
    Yu Zhu
    Zhoujun Shen
    [J]. International Urology and Nephrology, 2015, 47 : 1135 - 1141
  • [7] Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer
    Yan, Ting-Hua
    Lu, Sui-Wan
    Huang, Yong-Qing
    Que, Gan-Bo
    Chen, Jun-Hui
    Chen, Yong-Ping
    Zhang, Hong-Bin
    Liang, Xing-Lan
    Jiang, Jin-Hua
    [J]. TUMOR BIOLOGY, 2014, 35 (10) : 10249 - 10257
  • [8] Predicting recurrence and progression in stage TA T1 bladder cancer patients using EORTC risk tables
    Sylvester, R
    Van der Mejden, APM
    Oosterlinck, W
    Witjes, JA
    Kurth, KH
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 269 - 269
  • [9] Impact of tumour size on recurrence and progression in Ta/T1 carcinoma of the urinary bladder
    Jancke, Georg
    Rosell, Johan
    Jahnson, Staffan
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2011, 45 (06): : 388 - 392
  • [10] Patterns of early invasion in bladder cancer: Ta versus T1
    van der Kwast, TH
    [J]. UPDATE IN PATHOLOGY, PROCEEDINGS, 2003, : 506 - 507